Forma Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2020
March 30, 2021 at 07:20 am EDT
Forma Therapeutics Holdings, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, the company reported loss from operations was $32,807,000 against $26,039,000 a year ago. Net loss was $28,588,000 against $24,656,000 a year ago. Basic net loss per share of common stock was $0.68 against $11.31 a year ago. Diluted net loss per share of common stock was $0.68 against $11.48 a year ago.
For the full year, the company reported loss from operations was $124,212,000 against $40,450,000 a year ago. Net loss was $70,414,000 against $34,793,000 a year ago. Basic net loss per share of common stock was $3.22 against $20.70 a year ago. Diluted net loss per share of common stock was $3.22 against $21.08 a year ago.